Scarica l'app Stockscreener
2.39
0.84%
0.02
Dopo l'orario di chiusura:
2.37
-0.02
-0.84%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché IBRX Giù?
Forum
Previsione
Precedente Chiudi:
$2.37
Aprire:
$2.38
Volume 24 ore:
6.32M
Relative Volume:
0.73
Capitalizzazione di mercato:
$2.26B
Reddito:
$1.31M
Utile/perdita netta:
$-597.65M
Rapporto P/E:
-2.4639
EPS:
-0.97
Flusso di cassa netto:
$-425.62M
1 W Prestazione:
+2.58%
1M Prestazione:
-0.83%
6M Prestazione:
-20.86%
1 anno Prestazione:
-35.41%
Intervallo 1D:
$2.29
$2.40
Intervallo di 1 settimana:
$2.29
$2.47
Portata 52W:
$1.83
$7.48
Immunitybio Inc Stock (IBRX) Company Profile
Nome
Immunitybio Inc
Settore
Industria
Telefono
(844) 696-5235
Indirizzo
3530 JOHN HOPKINS COURT, SAN DIEGO
Confronta IBRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IBRX
Immunitybio Inc
|
2.39 | 2.25B | 1.31M | -597.65M | -425.62M | -0.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Immunitybio Inc Stock (IBRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-20 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2025-03-06 | Iniziato | H.C. Wainwright | Buy |
| 2025-01-10 | Iniziato | BTIG Research | Buy |
| 2023-05-12 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-08-03 | Iniziato | Jefferies | Buy |
Immunitybio Inc Borsa (IBRX) Ultime notizie
NK Cell Therapy Pipeline Outlook 2025: Clinical Trial Studies, EMA, PDMA, FDA Approvals, MOA, ROA, NDA, IND, and Companies - The Globe and Mail
What Went Wrong With ImmunityBio’s Executives Claims — and How Investors Could Still Win - TradingView
Detecting price anomalies in ImmunityBio Inc. with AIJuly 2025 Trade Ideas & AI Enhanced Execution Alerts - Newser
Is ImmunityBio Inc. stock entering bullish territory2025 Trading Volume Trends & Comprehensive Market Scan Insights - Newser
Using R and stats models for ImmunityBio Inc. forecastingJuly 2025 Spike Watch & Real-Time Stock Entry Alerts - Newser
Real time scanner hits for ImmunityBio Inc. explainedTrade Volume Summary & Accurate Trade Setup Notifications - Newser
Is ImmunityBio Inc. reversing from oversold territoryJuly 2025 Momentum & Reliable Intraday Trade Alerts - Newser
Measuring ImmunityBio Inc.’s beta against major indicesMarket Rally & Long-Term Growth Stock Strategies - Newser
Aug Sentiment: Can ImmunityBio Inc. stock double in the next yearWeekly Risk Summary & Advanced Technical Signal Analysis - khodrobank.com
Applying chart zones and confluence areas to ImmunityBio Inc.2025 Bull vs Bear & Expert-Curated Trade Recommendations - Newser
ImmunityBio Inc. stock volume spike explainedDollar Strength & Safe Capital Growth Trade Ideas - Newser
Will ImmunityBio Inc. bounce back from current supportQuarterly Performance Summary & Reliable Volume Spike Trade Alerts - Newser
Custom strategy builders for tracking ImmunityBio Inc.Bull Run & Technical Confirmation Trade Alerts - Newser
What’s next for ImmunityBio Inc. stock priceWeekly Profit Summary & Daily Volume Surge Trade Alerts - Newser
Should I hold or sell ImmunityBio Inc. nowJuly 2025 Action & High Accuracy Buy Signal Tips - khodrobank.com
How to build a custom watchlist for ImmunityBio Inc.Weekly Profit Report & Consistent Return Strategy Ideas - Newser
ImmunityBio Inc. stock prediction for this weekStop Loss & Low Drawdown Investment Strategies - Newser
Is ImmunityBio Inc. stock a smart retirement pickJuly 2025 Volume & Momentum Based Trading Ideas - khodrobank.com
What are the analyst revisions for DRUGIs ImmunityBio Inc. stock a good investment in YEARTrade Exit Summary & Real-Time Volume Analysis - khodrobank.com
Is ImmunityBio Inc. gaining market shareAnalyst Downgrade & Real-Time Market Trend Scan - khodrobank.com
Should value investors consider ImmunityBio Inc.July 2025 Sector Moves & Precise Trade Entry Recommendations - khodrobank.com
Can ImmunityBio Inc. stock double in the next year2025 Market Overview & AI Driven Price Predictions - khodrobank.com
Is ImmunityBio Inc. a speculative investmentJuly 2025 Final Week & Real-Time Stock Movement Alerts - khodrobank.com
Does ImmunityBio Inc. have high return on assetsTreasury Yields & Risk Managed Investment Strategies - خودرو بانک
Is ImmunityBio Inc.’s growth already priced inJuly 2025 Volume & Verified Stock Trade Ideas - khodrobank.com
ImmunityBio Inc. Charts Flash Early Recovery SignalsJuly 2025 Setups & Risk Controlled Stock Pick Alerts - beatles.ru
Does ImmunityBio Inc. have a sustainable dividendTrade Performance Summary & Step-by-Step Swing Trade Plans - khodrobank.com
What momentum shifts mean for ImmunityBio Inc.Weekly Trade Report & Fast Entry Momentum Trade Alerts - Newser
Is ImmunityBio Inc. stock technically oversoldAnalyst Downgrade & Low Risk Investment Opportunities - khodrobank.com
Fed Meeting: Is ImmunityBio Inc. forming a double bottomWeekly Trade Report & Safe Capital Investment Plans - khodrobank.com
Identifying reversal signals in ImmunityBio Inc.2025 Key Lessons & Technical Pattern Based Signals - Newser
What technical models suggest about ImmunityBio Inc.’s comeback2025 Technical Overview & Free Risk Controlled Daily Trade Plans - Newser
What’s ImmunityBio Inc.’s historical returnWeekly Volume Report & Trade Opportunity Analysis - khodrobank.com
Is ImmunityBio Inc. stock a value trapQuarterly Trade Summary & Stepwise Entry/Exit Trade Alerts - khodrobank.com
Comparing ImmunityBio Inc. in custom built stock radarsEarnings Growth Summary & Weekly Chart Analysis and Guides - Newser
ImmunityBio Inc. Chart Enters High Volatility Zone2025 Biggest Moves & High Return Stock Watch Alerts - beatles.ru
Neuroendocrine tumors Pipeline Analysis, 2025 by DelveInsight | RayzeBio, Inc., Camurus, Vyriad, Inc., ADC Therapeutics, Eli Lilly and Company, Biotheus Inc., ImmunityBio, Inc., Chimerix, Merck Sharp - Barchart.com
Chart based analysis of ImmunityBio Inc. trendsJuly 2025 Summary & Community Verified Swing Trade Signals - Newser
Statistical indicators supporting ImmunityBio Inc.’s strengthQuarterly Risk Review & Low Risk High Reward Ideas - Newser
Signal strength of ImmunityBio Inc. stock in tech scannersQuarterly Profit Review & Daily Growth Stock Investment Tips - Newser
Advanced analytics toolkit walkthrough for ImmunityBio Inc.2025 Market Sentiment & Free AI Powered Buy and Sell Recommendations - Newser
ImmunityBio Inc. Recovers — But Is It Sustainable getLinesFromResByArray error: size == 0 - thegnnews.com
Immunitybio Inc Azioni (IBRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Immunitybio Inc Azioni (IBRX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| SOON-SHIONG PATRICK | See remarks |
Feb 22 '25 |
Option Exercise |
0.00 |
114,329 |
0 |
29,588,261 |
| Sachs David C. | Chief Financial Officer |
Feb 22 '25 |
Option Exercise |
0.00 |
40,650 |
0 |
241,480 |
| Adcock Richard | CEO & President |
Feb 22 '25 |
Option Exercise |
0.00 |
152,439 |
0 |
412,585 |
| Simon Barry J. | Director |
Feb 22 '25 |
Option Exercise |
0.00 |
15,243 |
0 |
3,249,024 |
| Simon Barry J. | Director |
Jan 22 '25 |
Option Exercise |
2.00 |
110,020 |
219,864 |
3,233,781 |
| Adcock Richard | CEO & President |
Dec 31 '24 |
Option Exercise |
0.00 |
34,483 |
0 |
277,621 |
| Sachs David C. | Chief Financial Officer |
Dec 31 '24 |
Option Exercise |
0.00 |
30,397 |
0 |
216,235 |
| LAUER REGAN J | Chief Accounting Officer |
Dec 15 '24 |
Option Exercise |
0.00 |
21,031 |
0 |
115,365 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):